Surveillance for hepatocellular carcinoma: It is time to move forward
- PMID: 36064304
- PMCID: PMC9597219
- DOI: 10.3350/cmh.2022.0257
Surveillance for hepatocellular carcinoma: It is time to move forward
Keywords: Cancer screening; Hepatocellular carcinoma; Surveillance; Survival.
Conflict of interest statement
The authors have no conflicts to disclose.
Comment in
-
Correspondence on Editorial regarding "Impact of nationwide hepatocellular carcinoma surveillance on the prognosis in patients with chronic liver disease".Clin Mol Hepatol. 2023 Jan;29(1):182-184. doi: 10.3350/cmh.2022.0411. Epub 2022 Nov 22. Clin Mol Hepatol. 2023. PMID: 36417888 Free PMC article. No abstract available.
Comment on
-
Impact of nationwide hepatocellular carcinoma surveillance on the prognosis in patients with chronic liver disease.Clin Mol Hepatol. 2022 Oct;28(4):851-863. doi: 10.3350/cmh.2022.0037. Epub 2022 Jun 3. Clin Mol Hepatol. 2022. PMID: 36263667 Free PMC article.
Similar articles
-
Surveillance for hepatocellular carcinoma in patients with liver cirrhosis in India.Trop Gastroenterol. 2008 Oct-Dec;29(4):183-6. Trop Gastroenterol. 2008. PMID: 19323085 No abstract available.
-
Surveillance for hepatocellular carcinoma...a hotly debated issue.Acta Gastroenterol Belg. 2004 Jul-Sep;67(3):255-64. Acta Gastroenterol Belg. 2004. PMID: 15587332 Review.
-
Surveillance of the patients at high risk for developing hepatocellular carcinoma in Europe--between guidelines and reality.Ultraschall Med. 2013 Oct;34(5):483-4. doi: 10.1055/s-0033-1346750. Ultraschall Med. 2013. PMID: 24278973 No abstract available.
-
Towards a New Horizon for Individualized Surveillance Tools in Hepatocellular Carcinoma.Clin Gastroenterol Hepatol. 2022 Jan;20(1):25-27. doi: 10.1016/j.cgh.2021.04.041. Epub 2021 Apr 30. Clin Gastroenterol Hepatol. 2022. PMID: 33940226 No abstract available.
-
[Screening of hepatocellular carcinoma and surveillance of patients with cirrhosis: a public health issue].Rev Prat. 2013 Feb;63(2):222-5. Rev Prat. 2013. PMID: 23513790 Review. French.
Cited by
-
Correspondence on Editorial regarding "Impact of nationwide hepatocellular carcinoma surveillance on the prognosis in patients with chronic liver disease".Clin Mol Hepatol. 2023 Jan;29(1):182-184. doi: 10.3350/cmh.2022.0411. Epub 2022 Nov 22. Clin Mol Hepatol. 2023. PMID: 36417888 Free PMC article. No abstract available.
-
Regular Alpha-Fetoprotein Tests Boost Curative Treatment and Survival for Hepatocellular Carcinoma Patients in an Endemic Area.Cancers (Basel). 2023 Dec 28;16(1):150. doi: 10.3390/cancers16010150. Cancers (Basel). 2023. PMID: 38201578 Free PMC article.
-
METTL1-driven nucleotide metabolism reprograms the immune microenvironment in hepatocellular carcinoma: a multi-omics approach for prognostic biomarker discovery.Front Immunol. 2025 Apr 22;16:1582203. doi: 10.3389/fimmu.2025.1582203. eCollection 2025. Front Immunol. 2025. PMID: 40330476 Free PMC article.
-
Clinical practice guidelines and real-world practice for hepatocellular carcinoma in Taiwan: Bridging the gap.Clin Mol Hepatol. 2023 Apr;29(2):349-351. doi: 10.3350/cmh.2023.0082. Epub 2023 Mar 20. Clin Mol Hepatol. 2023. PMID: 36935648 Free PMC article. No abstract available.
-
The prime time for management of hepatocellular carcinoma in Hong Kong.Clin Mol Hepatol. 2023 Apr;29(2):345-348. doi: 10.3350/cmh.2023.0094. Epub 2023 Mar 9. Clin Mol Hepatol. 2023. PMID: 36907571 Free PMC article. No abstract available.
References
-
- Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–249. - PubMed
-
- European Association for the Study of the Liver EASL clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2018;69:182–236. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical